Skip to main content

Table 1 Sociodemographic and clinical description of bladder cancer cases diagnosed in Mallorca between 2006 and 2011 (N = 1914)

From: Cancer-specific survival by stage of bladder cancer and factors collected by Mallorca Cancer Registry associated to survival

Variable

Categories

N

%

% Valid

After MI

Sex

Women

268

14.0

14.0

 

Men

1646

86.0

86.0

 

Age

15–44

45

2.4

2.4

 

45–54

172

9.0

9.0

 

55–64

445

23.2

23.2

 

65–74

548

30.2

30.2

 

75 or +

674

35.2

35.2

 

Diagnostic method

Pathological

1843

96.3

96.3

 

Clinical

65

3.4

3.4

 

Unknown

6

0.3

0.3

 

Histology

Papillary transitional neoplasia

1096

57.3

57.3

 

Solid transitional neoplasia

713

37.3

37.3

 

Other histology and unspecified

105

5.5

5.5

 

Behaviour

Invasive

1160

60.6

60.6

 

In situ

680

35.5

35.5

 

Uncertain

74

3.9

3.9

 

Clinical or pathological tumour size (T_PT)

1

566

29.6

44.0

 

2

207

10.8

16.1

 

3

68

3.6

5.3

 

4a

58

3.0

4.5

 

4b

1

0.1

0.1

 

a (histology 8130 and behaviour in situ)

298

15.6

23.2

 

is (histology 8120 and behaviour in situ)

13

0.7

1.0

 

uncertain behaviour

74

3.9

5.8

 

Missing

629

32.9

  

Clinical or pathological regional lymph nodes (N_PN)

0

187

8.8

68.8

 

1

33

1.7

12.1

 

2

46

2.4

16.9

 

3

6

0.3

2.2

 

Missing

1642

85.8

  

Metastasis(M)

0

237

12.4

80.6

 

1

57

3.0

19.4

 

Missing

1620

84.6

  

Stagea

Ta

625

32.7

38.6

37.3

Tis

53

2.8

3.3

3.2

I

564

29.5

34.8

34.2

II

181

9.5

11.2

11.8

III

67

3.5

4.1

4.3

IV

129

6.7

8.0

9.1

No stage

74

3.9

  

Missing

221

11.5

  
  1. avalues imputed for each category of stage: Ta: 306 (27.7%); Tis: 27 (2.4%); I: 326 (29.5%); II: 184 (16.6%); III: 66 (5.9%); IV: 196 (17.7%)